Top Markets
#1 Islamic Coin Islamic Coin +151.54%
#2 Akedo Akedo +66.39%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.78%
#5 Velvet Velvet +41.51%
#6 Cross Cross +35.02%
#7 Black Phoenix Black Phoenix +34.13%
#8 Cap Cap +20.45%
#9 DoubleZero DoubleZero +15.18%
#10 GRVT Token GRVT Token +9.99%
Coin of the day
Islamic Coin Islamic Coin
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Helyezés a részvények között #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Részvényárfolyam
$0.0202
Utolsó szinkronizálás: 2024-11-19
Piaci kapitalizáció
$44.67K
Változás (1 nap)
-0.49%
Változás (1 év)
0.00%
Ország
IL
Kereskedés Notable Labs, Ltd. (NTBL)

Kategória

Healthcare
Notable Labs, Ltd. (NTBL) P/S aránya
P/S arány ekkor: August 2026 TTM: 7.72
Notable Labs, Ltd. legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi árbevétel aránya (P/S, TTM) 7.72. 2022 végén ez az arány 1.16K volt.
P/S arány története a(z) Notable Labs, Ltd. esetén 2015 és 2026 között
P/S arány az év végén
Év P/S arány Változtassa meg
2026 (TTM) 7.72 -41.88%
2023 13.29 -98.86%
2022 1.16K -93.42%
2021 17.67K 387.47%
2020 3.63K -4.00%
2019 3.78K 97.37%
2018 1.91K 289.61%
2017 491.09 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
P/S arány hasonló vállalatoknál vagy versenytársaknál
Vállalat P/S arány P/S arány különbség Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 27.92%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 33.38%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -35.54%
BE